Home > News > SDSU researches use of ethanol byproduct for cancer drug
July 10th, 2008
SDSU researches use of ethanol byproduct for cancer drug
Abstract:
The zein protein, a byproduct in the production of ethanol from corn, might someday help women in the fight against breast cancer, according to research being conducted at the South Dakota State University College of Pharmacy in Brookings, S.D.
Omathanu Perumal, assistant professor in pharmaceutical sciences at SDSU, said that while zein is predominantly used today as a moisture barrier coating in pharmaceutical tablets, candies, and paper products, it can be used in its nanoparticle form to deliver cancer drugs to cancer cells while bypassing healthy cells. He said initial tests using zein have produced "very promising" results in delivering the cancer-fighting drug Doxorubicin into breast cancer cells. According to the drug information provider Gold Standard, Doxorubicin is a chemotherapy drug used to treat a number of cancers, including bone, breast, stomach, lung, bladder, thyroid, ovarian, as well as leukemia, Wilms' tumor, and lymphoma.
Source:
ethanolproducer.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||